Literature DB >> 6338439

Human sympathetic ophthalmia. An analysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunochemistry, and correlative electron microscopy.

F A Jakobiec, C C Marboe, D M Knowles, T Iwamoto, W Harrison, S Chang, D J Coleman.   

Abstract

A case of human sympathetic ophthalmia, enucleated after surgical trauma, was studied by means of hybridoma-derived monoclonal antibodies, histochemistry, and transmission electron microscopy. The choroidal infiltrate was composed predominantly of T-lymphocytes of the suppressor/cytotoxic subset (OKT8+); only 5% of the cells were immunoglobulin-producing B-lymphocytes (kappa or lambda light chain positive), thereby explaining the well-known paucity of plasma cells in the infiltrate. The epithelioid cells and phagocytic histiocytes in the choroid were la+ and OKM1+, antigenic determinants specific for bone marrow-derived monocytes, and their cytoplasms exhibited histochemical reactivity for alpha-1-antichymotrypsin and lysozyme. Ultrastructurally, the choroidal epithelioid cells contained single melanin granules in the cytoplasm, but these were membrane-bound and frequently associated with lysosomal material, features militating against these cells being transformed choroidal melanocytes. By means of immunologic and ultrastructural analysis, the Dalen-Fuchs nodules were found to be composed of a mixture of histiocytes (la+ and OKM1+) and depigmented retinal pigment epithelial cells (la- and OKM1-); the latter cells focally formed desmosomes and displayed inclusions of lipofuscin. Scattered within the Dalen-Fuchs nodules were small numbers of T-lymphocytes of the suppressor/cytotoxic subset. We have concluded that the uveitis and retinal pigment epithelial changes are mediated by a T-cell, delayed hypersensitivity pathogenetic mechanism (cell-mediated immunity), possibly directed at surface membrane antigens that may be shared by photoreceptors, retinal pigment epithelial cells, and choroidal melanocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338439     DOI: 10.1016/s0161-6420(83)34602-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

Review 1.  Sympathetic ophthalmia: an autoimmune ocular inflammatory disease.

Authors:  C C Chan; M Mochizuki
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study.

Authors:  Emiko Furusato; DeFen Shen; Xiaoguang Cao; Bungo Furusato; Robert B Nussenblatt; Elisabeth J Rushing; Chi-Chao Chan
Journal:  Histol Histopathol       Date:  2011-09       Impact factor: 2.303

Review 3.  Endogenous posterior uveitis.

Authors:  J V Forrester
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

4.  Morphological variation of Dalén-Fuchs nodules in sympathetic ophthalmia.

Authors:  M Reynard; R S Riffenburgh; D S Minckler
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

Review 5.  Progress in uveitis.

Authors:  D J Spalton
Journal:  Br J Ophthalmol       Date:  1988-02       Impact factor: 4.638

6.  Fundal white dots: the spectrum of a similar pathological process.

Authors:  D Ben Ezra; J V Forrester
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

Review 7.  Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

Authors:  A D Dick
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

8.  Comparison of the expression of interferon gamma, IL2, IL4, and lymphotoxin mRNA in experimental autoimmune uveoretinitis.

Authors:  D G Charteris; S L Lightman
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

9.  Twenty cases of sympathetic ophthalmia.

Authors:  T Jennings; H H Tessler
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

10.  Conjunctival nodules associated with Vogt-Koyanagi-Harada disease.

Authors:  Kumiko Nakao; Yuka Shimonagano; Norihito Doi; Taiji Sakamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-14       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.